0000950170-24-069423.txt : 20240605 0000950170-24-069423.hdr.sgml : 20240605 20240605171143 ACCESSION NUMBER: 0000950170-24-069423 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khayal Tamer I CENTRAL INDEX KEY: 0001430462 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 241022941 MAIL ADDRESS: STREET 1: TRANSMEDICS INC STREET 2: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 ownership.xml 4 X0508 4 2024-06-03 0001756262 TransMedics Group, Inc. TMDX 0001430462 Khayal Tamer I C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 false true false false Chief Commercial Officer true Common Stock 2024-06-03 4 M false 1459 38.46 A 22302 D Common Stock 2024-06-03 4 M false 417 66.10 A 22719 D Common Stock 2024-06-03 4 M false 1084 13.28 A 23803 D Common Stock 2024-06-03 4 S false 105 129.92 D 23698 D Common Stock 2024-06-03 4 S false 219 130.79 D 23479 D Common Stock 2024-06-03 4 S false 539 131.87 D 22940 D Common Stock 2024-06-03 4 S false 921 132.71 D 22019 D Common Stock 2024-06-03 4 S false 567 133.67 D 21452 D Common Stock 2024-06-03 4 S false 152 134.66 D 21300 D Common Stock 2024-06-03 4 S false 457 135.97 D 20843 D Stock Option (Right to Buy) 38.46 2024-06-03 4 M false 1459 0.00 D 2031-02-24 Common Stock 1459 13125 D Stock Option (Right to Buy) 66.10 2024-06-03 4 M false 417 0.00 D 2033-02-20 Common Stock 417 13766 D Stock Option (Right to Buy) 13.28 2024-06-03 4 M false 1084 0.00 D 2032-02-22 Common Stock 1084 22750 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $129.30 to $130.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $130.315 to $131.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $131.30 to $132.295, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $132.315 to $133.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $133.31 to $134.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $134.33 to $135.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $135.37 to $136.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. By: /s/ Stephen Gordon, Attorney-in-Fact 2024-06-05